Replies to post #18488 on GTC Biotherapeutics (fka GTCB)

[biotechnewbee]

well,

it's just my opinion regarding a buy-out/partnership. but it is not an unlikely alternative to bankruptcy or to becoming a minority owner of your own company.

[vinmantoo]

read_this,

Yes there is a good chance there will be more dilution. Let's assume that GTCB won't be an a position to repay the LFB loan by June. That isn't the same as going bankrupt as the naysayers keep arguing. It means GTCB will need to generate more cash to keep operations going, not generate enough cash to repay the loan and keep operations going. Yes there will be more dilution.

Dew said he bailed out becuase of increased dilution. What is amusing is that Dew views every bit of news as a negative. It will be truly amusing to see how he spins passage of the FOB legislation as a negative for GTCB. You can't see how passage of the FOB legislation following up on FDA approval of rATIII won't be viewed as positives for GTCB, and by any potential pharma partner that might want to use GTCB's service to get into the lucrative biologicals market?

A new partner rATIII in Europe will mean some kind of payment to GTCB, and maybe some kind of payment from LEO for breach of contract. More importantly, GTCB will finally have someone to get rATIII in Europe expanded to pregnant HD women, and to push for sales in Europe to finally generate some income there, as well as get the all important DIC trial restarted,